×

Antisense inhibition of telomeric repeat binding factor 2 expression

  • US 6,300,132 B1
  • Filed: 12/17/1999
  • Issued: 10/09/2001
  • Est. Priority Date: 12/17/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. An antisense compound 8 to 30 nucleobases in length targeted to regions of a nucleic acid encoding a 5′

  • -UTR, a through 1809 or nucleotides 1839 through 1913 or nucleotides 2007 through 2413 of a 3′

    -UTR of human Telomeric repeat binding factor 2, wherein said antisense compound specifically hybridizes with said regions of a nucleic acid molecule encoding human Telomeric repeat binding factor 2 and inhibits the expression of human Telomeric repeat binding factor 2.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×